Menu
ncarol.com
  • Home
  • Business
  • Music
  • Health
  • Real Estate
  • Non-profit
  • Services
  • Finance
  • Beauty
ncarol.com

Relecura Makes Patent Innovation Research Platform Free to Coronavirus Researchers in Wake of Pandemic
ncarol.com/10051865

Trending...
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
Relecura Inc
PLEASANTON, Calif. - ncarol.com -- Relecura Inc., a leading provider of AI-powered patent and scientific innovation research,  today announced that Coronavirus researchers across the globe who are working on discovering a solution to the crisis will have free access to its premium research platform until May 31, 2020. Using Relecura's premium research platform, researchers can find and build on existing IP and patent research that will aid them in finding solutions to the current COVID-19 world pandemic.

Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.

"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."

Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.

More on ncarol.com
  • ANTOANETTA Partners With Zestacor Digital Marketing to Expand Online Presence for Handcrafted Luxury Jewelry
  • FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
  • The New Monaco of the South (of Italy)
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®

About Relecura:

Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.

Contact
George Koomullil
***@relecura.com


Source: Relecura Inc

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • Ascending Solutions Delivers 800 Toys to Boys & Girls Clubs of Gaston
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Indian Peaks Veterinary Hospital Launches Updated Dental Services Page for Boulder Pet Owners
  • Dugan Air Donates $10,000 to Indian Creek Schools
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
  • Wild Hermit Wellness and Bestselling Author Samantha McManus: A Synergy of Spirituality & Self-Care
  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion
  • Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
  • Shiny Stars Hosts Holiday Appreciation Lunch for Local First Responders and Library Staff
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder
  • VDG Virtuoso Builds Independent Label (VDG Records) and PR Infrastructure
  • TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
  • VDG Virtuoso Establishes Independent Creative Infrastructure Focused on Long-Term Artist Development
  • eJoule Inc Participates in Silicon Dragon CES 2026
_catLbl0 _catLbl1

Popular on ncarol.com

  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 131
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 109
  • VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure

Similar on ncarol.com

  • How Democrats Made Healthcare More Expensive in 2026
  • FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
  • Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute